Cargando…

Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab

Detalles Bibliográficos
Autores principales: Ostendorf, Lennard, Muench, Frédéric, Thormählen, Lena, Galbavý, Zaza, Körner, Roland, Nee, Jens, Schneider, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364176/
https://www.ncbi.nlm.nih.gov/pubmed/37479497
http://dx.doi.org/10.1136/rmdopen-2023-003238
_version_ 1785076795335245824
author Ostendorf, Lennard
Muench, Frédéric
Thormählen, Lena
Galbavý, Zaza
Körner, Roland
Nee, Jens
Schneider, Udo
author_facet Ostendorf, Lennard
Muench, Frédéric
Thormählen, Lena
Galbavý, Zaza
Körner, Roland
Nee, Jens
Schneider, Udo
author_sort Ostendorf, Lennard
collection PubMed
description
format Online
Article
Text
id pubmed-10364176
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103641762023-07-25 Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab Ostendorf, Lennard Muench, Frédéric Thormählen, Lena Galbavý, Zaza Körner, Roland Nee, Jens Schneider, Udo RMD Open Myositis BMJ Publishing Group 2023-07-21 /pmc/articles/PMC10364176/ /pubmed/37479497 http://dx.doi.org/10.1136/rmdopen-2023-003238 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Myositis
Ostendorf, Lennard
Muench, Frédéric
Thormählen, Lena
Galbavý, Zaza
Körner, Roland
Nee, Jens
Schneider, Udo
Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
title Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
title_full Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
title_fullStr Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
title_full_unstemmed Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
title_short Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
title_sort rescue combination treatment of anti-mda5-associated ards with daratumumab
topic Myositis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364176/
https://www.ncbi.nlm.nih.gov/pubmed/37479497
http://dx.doi.org/10.1136/rmdopen-2023-003238
work_keys_str_mv AT ostendorflennard rescuecombinationtreatmentofantimda5associatedardswithdaratumumab
AT muenchfrederic rescuecombinationtreatmentofantimda5associatedardswithdaratumumab
AT thormahlenlena rescuecombinationtreatmentofantimda5associatedardswithdaratumumab
AT galbavyzaza rescuecombinationtreatmentofantimda5associatedardswithdaratumumab
AT kornerroland rescuecombinationtreatmentofantimda5associatedardswithdaratumumab
AT neejens rescuecombinationtreatmentofantimda5associatedardswithdaratumumab
AT schneiderudo rescuecombinationtreatmentofantimda5associatedardswithdaratumumab